ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,110.62
1.23%
US Tech 100
17,247.20
1.59%
Dow Jones
38,299.25
0.56%
Brent Oil
88.20
0.06%
Bitcoin
64,001.89
-0.75%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. N4 Pharma Plc (N4P) Quote

N4 Pharma Plc

N4 Pharma Plc (N4P)

LSE
0.775
-0.05
(-6.06%)
Closed April 26 11:30AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.775
Bid
0.75
Ask
0.80
Volume
611,345
0.775 Day's Range 0.825
0.625 52 Week Range 2.175
Market Cap
1.394M
Previous Close
0.825
Open
0.825
Last Trade
500
@
0.8
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
812,265
Shares Outstanding
181,080,349
Dividend Yield
-
PE Ratio
-1.35
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-1.03M

About N4 Pharma Plc

Sector
Drug & Proprietary Stores
Industry
Computer & Office Equipment
Website
www.n4pharma.com
Headquarters
Derbyshire, Gbr
Founded
1990
N4 Pharma Plc is listed in the Drug & Proprietary Stores sector of the London Stock Exchange with ticker N4P. The last closing price for N4 Pharma was 0.83p. Over the last year, N4 Pharma shares have traded in a share price range of 0.625p to 2.175p.

N4 Pharma currently has 181,080,349 shares outstanding. The market capitalization of N4 Pharma is £1.39 million. N4 Pharma has a price to earnings ratio (PE ratio) of -1.35.

N4P Latest News

More News

N4 Pharma PLC N4 Pharma Webinar on SRI Collaboration

N4 Pharma PLC 26 April 2024     N4 Pharma plc  ("N4 Pharma" or the "Company")   N4 Pharma Webinar on SRI Collaboration   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company...

13 hours ago
RNS Non-Regulatory

N4 Pharma strikes partnership deal for intracellular delivery

N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc. N4 Pharma i ...

April 25 2024
Alliance News

N4 Pharma PLC Collaboration Agreement with SRI International Inc

N4 Pharma PLC 25 April 2024    25 April 2024 N4 Pharma plc  ("N4 Pharma" or the "Company")   Collaboration Agreement with SRI International Inc.   N4 Pharma Plc (AIM: N4P), the specialist...

April 25 2024
RNS Regulatory News

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

erbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 202 ...

April 23 2024
Alliance News

N4 Pharma PLC Final Results

N4 Pharma PLC 23 April 2024   23 April 2024   N4 Pharma plc   ("N4 Pharma" or the "Company")   Final Results   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

April 23 2024
RNS Regulatory News

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a suc ...

April 18 2024
Alliance News

N4 Pharma PLC Oral Delivery Update

N4 Pharma PLC 18 April 2024     18 April 2024 N4 Pharma plc  ("N4 Pharma" or the "Company")   Oral Delivery Update   N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing...

April 18 2024
RNS Regulatory News

N4 Pharma PLC Holding(s) in Company

N4 Pharma PLC 04 March 2024   TR-1: Standard form for notification of major holdings   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are...

March 04 2024
RNS Regulatory News

N4 Pharma PLC Holding(s) in Company

N4 Pharma PLC 29 February 2024   TR-1: Standard form for notification of major holdings   1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are...

February 29 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.075-8.823529411760.850.90.77519763640.83960588DE
40.12519.23076923080.650.9250.6512010210.8008654DE
12-0.075-8.823529411760.850.9250.6258122650.76802008DE
26-0.075-8.823529411760.851.40.62513940250.93254532DE
52-1.325-63.09523809522.12.1750.62510872131.09010532DE
156-7.325-90.43209876548.110.40.6259685483.57252646DE
260-3.025-79.60526315793.815.50.62514487306.21994661DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.27
(75.22%)
65.44M
NIVFNewGenIvf Group Ltd
$ 1.90
(46.15%)
55.87M
IBRXImmunityBio Inc
$ 7.3003
(42.86%)
25.32M
AGENAgenus Inc
$ 11.67
(40.60%)
2.51M
IFBDInfobird Company Ltd
$ 5.14
(39.30%)
3.87M
MFImF International Ltd
$ 2.285
(-78.11%)
20.09M
NWGLNature Wood Group Ltd
$ 5.6215
(-66.64%)
2M
ICLKiClick Interactive Asia Group Ltd
$ 1.24
(-50.99%)
672.39k
NUWENewellis Inc
$ 0.1613
(-44.19%)
17.61M
SGBXSafe and Green Holdings Corporation
$ 0.144
(-34.25%)
7.62M
PEGYPineapple Energy Inc
$ 0.0634
(22.16%)
305.24M
SQQQProShares UltraPro Short QQQ
$ 11.4316
(-4.74%)
117.09M
INTCIntel Corporation
$ 31.625
(-9.93%)
93.98M
TSLATesla Inc
$ 166.6928
(-2.05%)
87.2M
BDRXBiodexa Pharmaceuticals PLC
$ 1.27
(75.22%)
65.44M

Discussion

View Full Feed
koolmc koolmc 3 minutes ago
nice five's hitting now
CBIA
Tab$ Tab$ 3 minutes ago
Completely agree with you. I’m satisfied with any progress.
TPTW
sspalmo sspalmo 3 minutes ago
There was no stipulation of NASDAQ on being a part of this deal. The whole point of the "business combination agreement" with a SPAC that had $19 in cash was to sell more shares. Wasn't that the reason the Authorized Share count increased?
ENZC
tntgraham tntgraham 3 minutes ago
Quiet here today, Maybe next week.
PLPL
boston745 boston745 3 minutes ago
Looks like TA, that madg posted that so you could then post that im posting BS.

Its funny that Sintx selling its spinal IP and Amedica name to CTL is actually action aligned with Zimmer Biomets goal to license Sintx core tech outside of Hip/Knee as stated back in 2011.

SINT
misterfishman misterfishman 4 minutes ago
I envy you teach, you get to enjoy and love that beautiful new little one.
IGPK
Altitrade Partners Altitrade Partners 4 minutes ago
Once they get their filings current, the warning will disappear.
VAPR
Chartmaster Chartmaster 4 minutes ago
OK, but first you have to post your 20's you said you are holding.....waiting, tick tock!!! Lmao
IGPK
pinkslipjunkie pinkslipjunkie 4 minutes ago
Come on power hour close it up in the green.
HOLO
ALERTS100%to10000%GAIN ALERTS100%to10000%GAIN 5 minutes ago
Share Profile

Market Cap: Micro Cap
$4.30M
Shares Outstanding
22.74M
Shares held by Institutions
--
Enterprise Value
$8.10M
VHAI
Missile14b Missile14b 5 minutes ago
Maybe KISSINGER's getting their quads afterall. 🤣🙈
AHRO
Capsule Capsule 5 minutes ago
Solid facts. Thank you.

-Yes
BIEL
arizona1 arizona1 5 minutes ago
LOL. YOU guys are largely responsible for the existence of a Donald Trump because of the Democrats' policies and their candidates

Your stupidity is on you. Own it!
Demolition Man Demolition Man 5 minutes ago
I am being 100% sincere when I say thank you and the Belgium group for setting up these events. If not, team NioCorp would continue to get away with murder while being paid like kings. Thank you for at least trying to stay on top of this very sneaky team. WalterC you and AO seem like a good dudes w
NB
Real McCoy Real McCoy 5 minutes ago
Nice. Question for you: is it possible that since they announced this was liquidated in 2018 with nothing since, that that’s bad and there is no value here?
Batman412 Batman412 5 minutes ago
Lol crazy ppl who bought twos up 50 100% here come pumpers lol no 8k this is a scam
TONR
Rainer Rainer 5 minutes ago
COC - https://www.otcmarkets.com/otcapi/company/financial-report/399157/content
CIVX
nilremerlin nilremerlin 6 minutes ago
https://businessofcannabis.com/pressure-piles-on-dea-to-make-a-decision-on-cannabis-rescheduling-as-21-senators-demand-action/

I'm checking the Federal Register every day at 5pm, especially now that Mercury is Direct.
AYRWF
JusticeWillWin JusticeWillWin 6 minutes ago
Exactly, COOP's fair value was $200, now with the lower P/E even more IMO, see

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174283852

After the recent earnings, the PE ratio is now only 8.25, I think it was over 10 earlier, the stock should be trading
COOP
uber darthium uber darthium 6 minutes ago
“Before they went BR”… did you mean BANKRUPT ?

Long Duk Dong
Re: MFranny post# 112844
Friday, April 26, 2024 1:58:47 PM
Post# of 112852
Here's a more current presentation quoting biofloc survival rates as high as over 90%. Looks like Kings Shrimp Farm
SHMP
Monksdream Monksdream 6 minutes ago
OPTN new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/4/26/huhdvIMG_7742.gif
OPTN
spdpro spdpro 6 minutes ago
Have a good weekend > Later
mascale mascale 6 minutes ago
Liberian gold-mining boom is monitored worldwide: Literacy! (See U.S. Geological Survey, e.g.)

https://www.ceicdata.com/en/indicator/liberia/gold-production
HIRU

Your Recent History

LSE
N4P
N4 Pharma
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved